EPISODE · Aug 21, 2018 · 13 MIN
President & Chairman Anil Diwan of NanoViricides, Inc. (NASDAQ: NNVC) - August '18 update
from Stock Day Media · host Stock Day Media
President & Chairman Anil Diwan of NanoViricides, Inc. (NASDAQ:NNVC), returns to Stock Day to give an update on technological progress of clinical trials, raising capital for further research, and plans to commercialize various therapies. NASDAQ: NNVC # nanomedicine technology # immunotherapeutics # Virus-specific drugs # cold sores and genital # dengue viruses # HIV/AIDS # Immunotherapeutics # nano-biopharmaceuticals # nanomedicine technology # viral diseases Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
President & Chairman Anil Diwan of NanoViricides, Inc. (NASDAQ:NNVC), returns to Stock Day to give an update on technological progress of clinical trials, raising capital for further research, and plans to commercialize various therapies. NASDAQ: NNVC # nanomedicine technology # immunotherapeutics # Virus-specific drugs # cold sores and genital # dengue viruses # HIV/AIDS # Immunotherapeutics # nano-biopharmaceuticals # nanomedicine technology # viral diseases Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
President & Chairman Anil Diwan of NanoViricides, Inc. (NASDAQ: NNVC) - August '18 update
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.